Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benforey Plus is a multi-ingredient nutritional supplement developed by Sanrey Therapeutics, primarily indicated for the management of diabetic neuropathy, peripheral neuropathy, and supporting overall nerve health. It is formulated as a combination of benfotiamine (a highly bioavailable lipid-soluble derivative of thiamine), mecobalamin (an active coenzyme form of vitamin B12), alpha lipoic acid (a potent antioxidant), inositol, folic acid, chromium polynicotinate, and selenium dioxide. Together, these components work synergistically to protect nerve fibers, promote myelin sheath repair, enhance insulin sensitivity, and reduce oxidative stress and neuroinflammation associated with diabetic complications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Benforey Plus.